Campaign ' 88

Michael Dukakis Governor of Massachusetts since 1982 and from 1974 to 1978. When U.S. presidential candidates take to the stump, science and technology policy is not among the principal topics they address. Press them about specific proposals-whether they would reinstitute the President's Science Advisory Committee, for example, or how they would pay for a space station or for sequencing the human genome-and many veer off into abstractions. While they may be more comfortable talking abou

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

When U.S. presidential candidates take to the stump, science and technology policy is not among the principal topics they address. Press them about specific proposals-whether they would reinstitute the President's Science Advisory Committee, for example, or how they would pay for a space station or for sequencing the human genome-and many veer off into abstractions. While they may be more comfortable talking about jobs, education, national security and foreign relations, it's nevertheless clear that the contenders for the Democratic and Republican presidential nominations have differing visions of issues that touch on science policy. Some favor shifting more federal support to civilian R&D others believe that government research efforts should be focused on military programs. Nearly all of them support the federal R&D tax credit, but while some would like to see it phased out eventually, others hope that it can be made permanent or even increased. In an effort to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies